Patent classifications
C07F1/10
HETERODIMERIC CORE-SHELL NANOPARTICLE IN WHICH RAMAN-ACTIVE MOLECULES ARE LOCATED AT A BINDING PORTION OF A NANOPARTICLE HETERODIMER, USE THEREOF, AND METHOD FOR PREPARING SAME
A nanoparticle heterodimer in which Raman-active molecules are located at a binding portion of the nanoparticle heterodimer is disclosed. A core-shell nanoparticle heterodimer includes a gold or silver core having a surface to which oligo nucleotides are bonded; and a gold or silver shell covering the core. In addition, a core-shell nanoparticle dimer, a method for preparing same, and uses thereof are disclosed.
SYNTHESIS AND ANTIMICROBIAL USES OF DINUCLEAR SILVER(I) PYRAZOLATES
Novel dinuclear silver(I) pyrazolido complexes and methods of synthesizing them are provided. Advantageously, the novel silver(I) pyrazolido complexes have excellent antimicrobial activity and methods of using said complexes to treat bacterial, fungal, and viral infections are also provided.
ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
An organometallic compound is represented by Formula 1 and an organic light-emitting device includes the same. The organic light-emitting device includes: a first; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode and including an emission layer, wherein the organic layer includes an organometallic compound represented by Formula 1.
##STR00001##
Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates
Novel dinuclear silver(I) pyrazolido complexes and methods of synthesizing them are provided. Advantageously, the novel silver(I) pyrazolido complexes have excellent antimicrobial activity and methods of using said complexes to treat bacterial, fungal, and viral infections are also provided.
ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
The present disclosure provides a compound of Formula I
##STR00001## wherein M is a metal selected from the group consisting of Cu, Ag, and Au; T is a five-membered or six-membered heterocyclic ring, which is optionally substituted, wherein T includes a carbene carbon coordinated to M, or T is aromatic and includes a sp.sup.2 nitrogen coordinated to M; L is a group comprising a coordinating member selected from the group consisting of C, N, O, S, and P, wherein the coordinating member coordinates L to M; and Q.sup.1 and Q.sup.2 are each independently a linker, wherein the linker connects T to the coordinating member of L to form a macrocyclic ligand coordinated to M.
ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
The present disclosure provides a compound of Formula I
##STR00001## wherein M is a metal selected from the group consisting of Cu, Ag, and Au; T is a five-membered or six-membered heterocyclic ring, which is optionally substituted, wherein T includes a carbene carbon coordinated to M, or T is aromatic and includes a sp.sup.2 nitrogen coordinated to M; L is a group comprising a coordinating member selected from the group consisting of C, N, O, S, and P, wherein the coordinating member coordinates L to M; and Q.sup.1 and Q.sup.2 are each independently a linker, wherein the linker connects T to the coordinating member of L to form a macrocyclic ligand coordinated to M.
NOVEL HEAVY METAL ION-HEMATEIN-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES
The present invention relates to specific complexes comprising heavy metal ions having an atomic number of 23 or higher and 83 or lower (in particular Ag.sup.1+, Ba.sup.2+, Pb.sup.2+, Gd.sup.3+ and Bi.sup.3+) and one or more hematein ligand(s). In particular, the invention relates to the use of the complexes as ex vivo contrast agents for a computed tomography scanning of a biological sample. Moreover, the invention relates to specific ex vivo methods for investigating a biological sample by means of computed tomography scanning methods, wherein the method comprises staining the biological sample with a solution comprising one or more of the complex(es); or wherein the method comprises staining the biological sample with a staining solution comprising hematein, and separately contacting the biological sample with one or more staining solution(s) comprising one or more heavy metal ions having an atomic number of 23 or higher and 83 or lower (in particular Ag.sup.1+, Ba.sup.2+, Pb.sup.2+, Gd.sup.3+ and Bi.sup.3+).
Preparation and use of silver sulfadiazine-immobilized fillers
Silver sulfadiazine-immobilized inorganic fillers are described, and their synthesis is presented. The fillers are believed to have utility in dental composites and dental adhesives to achieve potent, long-term, and none-leaching antimicrobial effects.
Preparation and use of silver sulfadiazine-immobilized fillers
Silver sulfadiazine-immobilized inorganic fillers are described, and their synthesis is presented. The fillers are believed to have utility in dental composites and dental adhesives to achieve potent, long-term, and none-leaching antimicrobial effects.
Graphene oxide modified thermoset monomer and synthesis thereof
A monomer is provided for a thermoset molding compound. The monomer is also polymerized with conventional monomers to form thermoplastic polymers. Graphene oxide is used to chelate metal ions to form a graphene oxide chelate that is coupled to a monomer retaining an aliphatic unsaturation capable of free radical polymerization reaction. Inclusion of a metal ion chelated to the graphene oxide affords control over the conductivity of the resultant article. In some embodiments, the monomer is found polymerized into a resulting article proximal to the article surface.